News Category
A Phase 3 trial shows that combining two immunotherapy drugs significantly extends survival in patients with a deadly form of lung cancer, offering ne...
Scientists have developed smart polymeric nanoparticles that respond to tumor microenvironment signals to deliver immunotherapy precisely, potentially...
Scientists at the University of North Carolina have engineered immune cells that selectively destroy acute myeloid leukemia while sparing healthy bloo...
GeoVax Labs emphasizes the strategic role of its Gedeptin platform in enhancing checkpoint inhibitor efficacy against immunologically cold tumors by r...
The NHS in England is upgrading cancer treatment by offering a one-minute injection of pembrolizumab instead of a lengthy infusion, benefiting thousan...
A systematic review in JAMA Network Open suggests that earlier administration of immune checkpoint inhibitors could improve survival in patients with ...
Johns Hopkins researchers found that disrupting fructose metabolism in group 3 medulloblastoma cells slows tumor growth and enhances immune response i...
Immunologists have discovered how cancer cells reprogram immune cells to support cancer growth, a finding that could help improve immunotherapy respon...
GeoVax Labs highlights its Gedeptin therapy as a potential immune-sensitizing platform that could enhance checkpoint inhibitors, addressing the challe...
